Use of superoxide dismutase (SOD) in patients with temporomandibular joint dysfunction--a preliminary study.
The aim of this preliminary study was to investigate and assess the effect of intra-articular injection of superoxide dismutase (SOD) in patients with temporomandibular joint (TMJ) dysfunction who had not responded to conservative therapy in a first study. Thirty joints in 29 patients were studied. The results showed that intra-articular injection of superoxide dismutase was effective in 25 joints (83%). It was concluded that intra-articular injection of superoxide dismutase may be an alternative therapy for patients with TMJ dysfunction who fail to respond to conservative treatment.
Lin
Y
Y
Department of Oral and Maxillofacial Surgery, University of Cologne, Germany.
Pape
H D
HD
Friedrich
R
R
D000328:Adult; D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000627:therapeutic use; D005157:Facial Pain / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007270:Injections, Intra-Articular; D008297:Male; D008667:Metalloproteins / Q000627:therapeutic use*; D008875:Middle Aged; D016059:Range of Motion, Articular; D013482:Superoxide Dismutase / Q000008:administration & dosage / Q000627:therapeutic use*; D013705:Temporomandibular Joint Disorders / Q000188:drug therapy*; D016896:Treatment Outcome
D000894:Anti-Inflammatory Agents, Non-Steroidal; D008667:Metalloproteins; D013482:Superoxide Dismutase; C005180:orgotein